Beyond the Scan: New Research Refines the Role of Coronary Calcium Testing in Heart Health on October 1, 2026 Posted by
Beyond the Mission: Meet Lauren Belsky, the Engine Behind the Alliance for Aging Research’s Growth on October 1, 2026 Posted by
Honoring the Pillars of Our Community: Celebrating World Senior Citizens Day on October 1, 2026 Posted by
Beyond the Sugar Trap: Navigating the WHO’s Controversial Stance on Non-Sugar Sweeteners on October 1, 2026 Posted by
The Gut-Brain Link: New UCSF Study Links Ultra-Processed Foods to Depression on October 1, 2026 Posted by
The Weight of Devotion: Reflecting on the "Widowhood Effect" Following the Passing of Dolly Parton on October 1, 2026 Posted by
Beyond the Scan: New Research Refines the Role of Coronary Calcium Testing in Heart Health on October 1, 2026 Posted by
Beyond the Mission: Meet Lauren Belsky, the Engine Behind the Alliance for Aging Research’s Growth on October 1, 2026 Posted by
Honoring the Pillars of Our Community: Celebrating World Senior Citizens Day on October 1, 2026 Posted by
Posted in Chronic Disease Management A New Frontier in Oncology: FDA Approves Tudriqev for Advanced Melanoma on October 1, 2026
Posted in Chronic Disease Management A New Frontier in Oncology: FDA Grants Historic Approval to Tudriqev for Advanced Melanoma on September 30, 2026
Posted in Chronic Disease Management A New Frontier in Oncology: FDA Grants Accelerated Approval to Tudriqev for Advanced Melanoma on September 28, 2026
Posted in Chronic Disease Management A New Frontier in Oncology: FDA Approves Tudriqev for Advanced Melanoma on September 21, 2026
Posted in Chronic Disease Management A New Frontier in Oncology: FDA Approves Tudriqev for Advanced Melanoma on September 14, 2026
Posted in Cancer Recovery A New Frontier in Oncology: FDA Approves Tudriqev for Advanced Melanoma on September 7, 2026
Posted in Chronic Disease Management A New Frontier in Oncology: FDA Approves Tudriqev for Advanced Melanoma on August 31, 2026
Posted in Chronic Disease Management A New Frontier in Oncology: FDA Approves Tudriqev for Advanced Melanoma on August 24, 2026
Posted in Digital Health Tools A New Era in Oncology: Replimune Secures FDA Approval for Tudriqev, Challenging the Status Quo in Advanced Melanoma on August 8, 2026
Posted in Medical Innovations A New Frontier or a Regulatory Gamble? FDA Grants Accelerated Approval to Vusolimogene Oderparepvec for Advanced Melanoma on August 7, 2026
